President & CEO
Mr. Ford has over twenty-five years of experience in the pharmaceutical industry serving in executive management roles in operations, business and corporate development and strategic planning. Mr. Ford’s diversified background includes leadership experience in biotech, drug delivery, branded and generic drug companies. He served as President and COO of RTP Pharma/Skye Pharma Canada. He has also held positions with major and mid-sized pharmaceutical companies including Boehringer Ingelheim Pharmaceuticals, Mylan Laboratories and CollaGenex Pharmaceuticals. Mr. Ford holds a BS in Industrial Engineering and an MBA from West Virginia University.
Mr. Lavan has over 17 years of experience in the pharmaceutical industry serving in accounting and financial roles including strategic planning, supply-chain, and budget & planning. Mr. Lavan has been successful in establishing and implementing accounting standards and financial operations procedures for small to mid-size start-up companies. Prior to Akrimax, he served as Director of Accounting Operations & Systems at Triax Pharmaceuticals, LLC, and also has spent his career with Reliant Pharmaceuticals, Integra Life Sciences & Alpharma Pharmaceuticals in numerous roles of increasing responsibility. Mr. Lavan earned a BS in Accounting from Kean University.